[go: up one dir, main page]

ES2111083T3 - Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno). - Google Patents

Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno).

Info

Publication number
ES2111083T3
ES2111083T3 ES92920802T ES92920802T ES2111083T3 ES 2111083 T3 ES2111083 T3 ES 2111083T3 ES 92920802 T ES92920802 T ES 92920802T ES 92920802 T ES92920802 T ES 92920802T ES 2111083 T3 ES2111083 T3 ES 2111083T3
Authority
ES
Spain
Prior art keywords
compositions containing
quinolones
stirene
sulphonate
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92920802T
Other languages
English (en)
Inventor
Yusuf Ali
Rajni Jani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Application granted granted Critical
Publication of ES2111083T3 publication Critical patent/ES2111083T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES FARMACEUTICAS ACUOSAS CONTENIENDO UNA COMBINACION SINERGICA DE UNA QUINOLONA Y UN POLIMERO ACIDO SULFONICO DE POLIESTIRENO, DONDE LAS COMPOSICIONES SON SOLUCIONES LIMPIAS QUE RESULTAN CONFORTABLES Y TIENEN LIBERACION SOSTENIDA. SE DESCRIBEN METODOS PARA USO DE LAS COMPOSICIONES. ESTE TIPO DE FORMULACION ES PARTICULARMENTE UTIL CON QUINOLONAS DEL TIPO DE CIPROFLOXACINA, AUMENTANDO CONSIDERABLEMENTE LA SOLUBILIDAD DE ESTAS QUINOLONAS, HACIENDO FACTIBLE PODER TENER SOLUCIONES ACUOSAS QUE CONTIENEN TALES QUINOLONAS EN, O CERCA DE, PH FISIOLOGICO.
ES92920802T 1991-09-17 1992-09-11 Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno). Expired - Lifetime ES2111083T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76110491A 1991-09-17 1991-09-17

Publications (1)

Publication Number Publication Date
ES2111083T3 true ES2111083T3 (es) 1998-03-01

Family

ID=25061139

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92920802T Expired - Lifetime ES2111083T3 (es) 1991-09-17 1992-09-11 Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno).

Country Status (9)

Country Link
US (1) US5679336A (es)
EP (1) EP0604570B1 (es)
AT (1) ATE162081T1 (es)
AU (1) AU2672892A (es)
DE (1) DE69224071T2 (es)
DK (1) DK0604570T3 (es)
ES (1) ES2111083T3 (es)
GR (1) GR3026209T3 (es)
WO (1) WO1993005816A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2106680B1 (es) * 1995-08-03 1998-07-01 Vita Invest Sa Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
US5695882A (en) * 1995-08-17 1997-12-09 The University Of Montana System for extracting soluble heavy metals from liquid solutions
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
EP1800687A3 (en) * 1999-05-13 2009-12-30 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
US6290946B1 (en) 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
US6270755B1 (en) * 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
ATE411047T1 (de) * 1999-07-14 2008-10-15 Schering Plough Ltd Maskieren des geschmacks der oralen flüssigen chinolon-zubereitungen mit ionenaustauscherharzen
US6514492B1 (en) 1999-07-14 2003-02-04 Schering-Plough Veterinary Corporation Taste masking of oral quinolone liquid preparations using ion exchange resins
AU776609B2 (en) 1999-09-24 2004-09-16 Novartis Ag Topical suspension formulations containing ciprofloxacin and dexamethasone
ES2199873T3 (es) * 1999-11-01 2004-03-01 Alcon Inc. Composiciones farmaceuticas que contienen un farmaco antibiotico de fluoroquinolona y goma xantan.
CA2314494A1 (en) 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Anionic polymers as species specific antibacterial agents
DK1305033T3 (da) 2000-07-28 2005-01-31 Alcon Inc Farmaceutiske pæaparater indeholdende tobramycin og xanthangummi
US6743439B1 (en) * 2001-06-27 2004-06-01 Alcon, Inc. Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride
EP1429780B1 (en) 2001-09-21 2005-12-21 Alcon, Inc. Method of treating middle ear infections
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
AU2010216348B2 (en) * 2009-02-18 2015-01-22 Aradigm Corporation pH-modulated formulations for pulmonary delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
US4292317A (en) * 1977-09-20 1981-09-29 Laboratorie Roger Bellon 1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4615882A (en) * 1982-09-27 1986-10-07 Stockel Richard F Disinfectant solution for contact lens
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung

Also Published As

Publication number Publication date
WO1993005816A1 (en) 1993-04-01
ATE162081T1 (de) 1998-01-15
GR3026209T3 (en) 1998-05-29
DE69224071D1 (de) 1998-02-19
US5679336A (en) 1997-10-21
EP0604570A1 (en) 1994-07-06
EP0604570B1 (en) 1998-01-14
AU2672892A (en) 1993-04-27
DK0604570T3 (da) 1998-09-14
DE69224071T2 (de) 1998-05-07

Similar Documents

Publication Publication Date Title
ES2111083T3 (es) Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno).
DK354785D0 (da) Stabile salte af s-adenosyl-l-methionin med polyanioner
ATE376423T1 (de) Gelierende wässrige pharmazeutische zusammensetzungen
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
NO970051L (no) Vandige risperidon formuleringer
DE69908819D1 (de) Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
ATE148610T1 (de) Antimikrobielle mittel sowie substituierte 2- cyclohexan-1-yl-amin-derivate und deren herstellung
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
ATE526022T1 (de) Stabilisierte zusammenstellungen die benzimidazole enthalten
CA2447924A1 (en) Olopatadine formulations for topical administration
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
BR0005915A (pt) Comprimido matriz que possibilita a liberação prolongada de trimetazidina após a administração pela via oral
DK0866791T3 (da) Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler
DK0656015T3 (da) Nye inklusionskomplekser af nimesulidsalt med cyclodextrin
KR890005088A (ko) 4- 아미노피리딘 유도체 및 그의 산 부가염
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
ATE259813T1 (de) Triazolopyrimidinderivate
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
DK1102594T3 (da) Anvendelse af natriumchlorid til nedsættelse af den gastrointestinale toxicitet af derivater af camptothecin
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
ES2195819T3 (es) Formulaciones oftalmicas acuosas antibacterianas que contiene ofloxacino y chitosan.
PT99091A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da triazina e da pirimidina, como ingredientes activos, destinadas a reverter a resistencia aos agentes anticancerosos e antimalaricos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 604570

Country of ref document: ES